John Kaldor

InstitutionKirby Institute for Infection and Immunity in Society
AddressAustralia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 1 publications in October 2020 and November 2020 and December 2020 and February 2021 and June 2021 and July 2021
    All Publications
    Bar chart showing 386 publications over 20 distinct years, with a maximum of 30 publications in 2012 and 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Liu B, Spokes P, He W, Kaldor J. High risk groups for severe COVID-19 in a whole of population cohort in Australia. BMC Infect Dis. 2021 Jul 16; 21(1):685. PMID: 34266396.
      Citations:    Fields:    Translation:Humans
    2. Liu B, Jayasundara D, Pye V, Dobbins T, Dore GJ, Matthews G, Kaldor J, Spokes P. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Reg Health West Pac. 2021 Jul; 12:100193. PMID: 34189493.
      Citations: 2     
    3. Gidding HF, Machalek DA, Hendry AJ, Quinn HE, Vette K, Beard FH, Shilling HS, Hirani R, Gosbell IB, Irving DO, Hueston L, Downes M, Carlin JB, O'Sullivan MV, Dwyer DE, Kaldor JM, Macartney K. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Med J Aust. 2021 03; 214(4):179-185. PMID: 33538019.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    4. Burrell AJ, Pellegrini B, Salimi F, Begum H, Broadley T, Campbell LT, Cheng AC, Cheung W, Cooper DJ, Earnest A, Erickson SJ, French CJ, Kaldor JM, Litton E, Murthy S, McAllister RE, Nichol AD, Palermo A, Plummer MP, Ramanan M, Reddi BA, Reynolds C, Trapani T, Webb SA, Udy AA. Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic. Med J Aust. 2021 01; 214(1):23-30. PMID: 33325070.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    5. Liu B, Spokes P, Alfaro-Ramirez M, Ward K, Kaldor J. Hospital outcomes after a COVID-19 diagnosis from January to May 2020 in New South Wales Australia. Commun Dis Intell (2018). 2020 Nov 24; 44. PMID: 33357174.
      Citations: 3     Fields:    Translation:Humans
    6. van Bockel D, Munier CML, Turville S, Badman SG, Walker G, Stella AO, Aggarwal A, Yeang M, Condylios A, Kelleher AD, Applegate TL, Vallely A, Whiley D, Rawlinson W, Cunningham P, Kaldor J, Guy R. Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing. Viruses. 2020 10 23; 12(11). PMID: 33114233.
      Citations: 11     Fields:    Translation:HumansCells